ask="8.45"
ask_size="400"
average_daily_volume="53068"
bid="5.50"
bid_size="500"
book_value="-19.19"
change="+0.11"
change_from_200_day_moving_average="-0.14"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-30.22"
change_From_52_week_low="1.21"
change_in_percent="+1.53%"
close="7.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.99"
high_52_weeks="37.52"
last_trade_date="1/20/2017"
last_trade_price="7.30"
last_trade_size="102"
last_trade_time="4:00pm"
low="6.82"
low_52_weeks="6.09"
market_capitalization="17.79M"
moving_average_200_day="7.44"
moving_average_50_day="7.20"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.83%"
percent_change_from_50_day_moving_average="+1.39%"
percent_change_from_52_week_high="-80.54%"
percent_change_from_52_week_low="+19.87%"
previous_close="7.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.89"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="0.43"
stock_exchange="NGM"
symbol="KALV"
volume="99527"
weeks_range_52="6.09 - 37.52"
